COVID19

FDA rejects antidepressant seen as possible Covid-19 treatment

FDA rejects antidepressant seen as possible Covid-19 treatment

The Food and Drug Administration declined Monday to authorize a 30-year-old generic antidepressant as a treatment for Covid-19, dealing a major blow to a small group of doctors who have organized around the pill for months, arguing that it could provide a cheap and accessible way to prevent hospitalizations and death both in the U.S. …

FDA rejects antidepressant seen as possible Covid-19 treatment Read More »

Liz Atkinson, manager of the Quicksilver store at the Outlets at Traverse Mountain in Lehi, cleans a terminal after a transaction on May 1, 2020. Many businesses began encouraging transactions with plastic debit and credit cards as a safety measure to fight the spread of COVID-19. Now, a study from BYU says that plastic payment cards are actually worse for carrying the coronavirus than cash and coins.

Cold, hard, sanitary cash? BYU study finds going cashless to prevent COVID-19 was ‘useless’

Liz Atkinson, manager of the Quicksilver store at the Outlets at Traverse Mountain in Lehi, cleans a terminal after a transaction on May 1, 2020. Many businesses began encouraging transactions with plastic debit and credit cards as a safety measure to fight the spread of COVID-19. Now, a study from BYU says that plastic payment …

Cold, hard, sanitary cash? BYU study finds going cashless to prevent COVID-19 was ‘useless’ Read More »

Emergent BioSolutions discarded ingredients for 400 million COVID-19 vaccines, probe finds

Emergent BioSolutions discarded ingredients for 400 million COVID-19 vaccines, probe finds

Between March 2020 and February 2022, vaccine-maker Emergent BioSolutions was forced to discard or destroy up to 400 million doses’ worth of the key component of both Johnson & Johnson’s and AstraZeneca’s coronavirus vaccine due to quality-control issues, according to a congressional report published Tuesday — a figure that reflects more than five times what …

Emergent BioSolutions discarded ingredients for 400 million COVID-19 vaccines, probe finds Read More »

'Non-Starter' to Authorize COVID-19 Vaccine for Infants: Dr. Peter McCullough

‘Non-Starter’ to Authorize COVID-19 Vaccine for Infants: Dr. Peter McCullough

Moderna has requested the U.S. Food and Drug Administration (FDA) to grant an emergency use authorization (EUA) for its COVID-19 vaccine for children as young as 6 months. However, according to Dr. Peter McCullough, such authorization shouldn’t be granted because there’s almost no clinical benefit for children that young. Pfizer is also working on data for a three-dose …

‘Non-Starter’ to Authorize COVID-19 Vaccine for Infants: Dr. Peter McCullough Read More »